Agenus reported $18.95M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.06B 110M
Agenus AGEN:US $ 18.95M 3.02M
Amgen AMGN:US $ 1.23B 197M
AstraZeneca AZN:LN 3.06B 1.03B
Bristol Myers Squibb BMY:US $ 1.83B 523M
Celldex Therapeutics CLDX:US $ 6.91M 670K
Chemocentryx CCXI:US $ 26.01M 2.72M
CSL CSL:AU $ 748M 276.7M
Dynavax Technologies DVAX:US $ 31.46M 2.66M
Eli Lilly And LLY:US $ 1.56B 34.1M
Genocea Biosciences GNCA:US $ 3.6M 473K
Gilead Sciences GILD:US $ 1.08B 567M
GlaxoSmithKline GSK:LN 2.68B 227M
Glaxosmithkline GSK:US 2.68B 227M
Immunogen IMGN:US $ 16.65M 3.07M
Intrexon XON:US $ 19.58M 2.81M
Jiangsu Hengrui Me. 600276:CH 2.33B 1.35B
Johnson & Johnson JNJ:US $ 5.94B 1.22B
Karyopharm Therapeutics KPTI:US $ 38.77M 4.21M
Macrogenics MGNX:US $ 16.25M 670K
Merck MRK:GR 1.37B 172M
Merk MRK:US $ 2.3B 518M
Northwest Biotherapeutics NWBO:US 7.87M 1.38M
Novartis NOVN:VX 3.5B 486M
Novavax NVAX:US $ 95.99M 11.78M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Rigel Pharmaceuticals RIGL:US $ 27.4M 2.89M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Veracyte VCYT:US $ 44.14M 15.82M
YTE INCY:US $ 209.58M 16.62M